The Indian spirometers market is expected to grow at a compound annual growth rate (CAGR) of approximately 5% between 2018 and 2028 due to rise in the prevalent cases of chronic obstructive pulmonary disease (COPD), according to GlobalData, a leading data and analytics company.
GlobalData forecasts the prevalent cases of COPD in India to increase from 55 million in 2018 to 62 million in 2028. Smoking, growing air pollution, high consumption of biomass fuel and industrial exposure to dust and chemicals are major risk factors for COPD.
The company’s report, ‘Spirometers – Anesthesia & Respiratory Devices Market Analysis and Forecast Model’ reveals that increasing aging population and rising incidence of COPD and asthma are set to drive the Indian spirometers market during the outlook period.
Pratibha Thammanabhatla, Medical Devices Analyst at GlobalData, comments: “There is an urgent need for India to spread awareness, diagnose and manage COPD.
“The usage of spirometry, the gold-standard diagnostic test for COPD in India, is increasing over time but not at the desired level due to high cost of spirometers and lack of trained healthcare professionals to interpret results.”
Thammanabhatla concludes: “COPD is an alarming public health issue in India and needs immediate attention as the disease if not managed properly, worsens over time.
“The Government should consider measures to reduce air pollution and encourage private companies to invest in R&D capabilities to produce cost-effective and high quality medical devices. Individuals should make lifestyle changes such as reducing household air pollution and quit smoking to manage COPD.”